A report in China claims a hospital has launched the country’s first-in-human clinical trial of an invasive brain-computer interface (BCI). Global Times reported that the Shanghai-based Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) at the Chinese Academy of Sciences, in collaboration with Fudan University’s Huashan Hospital, launched the trial earlier this year. According […]
China
GE HealthCare could be affected by China’s anti-dumping probe
GE HealthCare could be among the companies affected by a Chinese government probe into whether lower-priced medical CT tubes from the U.S. and India are getting dumped into the East Asian giant’s market. The probe comes at the same time that the Trump administration has launched a global trade war that includes major tariffs against […]
Microport laparoscopic surgical robot wins regulatory nod in China
MicroPort MedBot recently announced that its Toumai SP laparoscopic surgical robot has received National Medical Products Administration approval in China. The approval for the Toumai SP system covered clinical uses across urology, general surgery, and gynecology, according to a March 20 news release from MicroPort. [Get key insights on the surgical robotics market in our […]
GE HealthCare taps former J&J leader as president, CEO for China
GE HealthCare announced today that its president and CEO for China plans to retire and it named a successor. Yihao Zhang, GE HealthCare’s president and CEO for China, plans to retire, effective July 1. The company picked Will Song, a veteran of more than 20 years at Johnson & Johnson, to become the new president […]
Philips stock sinks on Q3 misses, declines in China lead to guidance cut
Philips (NYSE:PHG) shares took a big hit today on third-quarter results that came up shy of the consensus forecast on Wall Street. Shares of PHG fell nearly 17% to $26.47 apiece in early-morning trading today. The Amsterdam-based medtech giant reported profits of $195.8 million. That equals 21¢ per share on sales of $4.7 billion for […]
Boston Scientific wins Farapluse approval in China
Boston Scientific (NYSE: BSX) has gained access to another huge market for its Farapulse pulsed field ablation system for treating atrial fibrillation. “I’m thrilled to share that the novel Farapulse pulsed field ablation system has received approval in China! With 12 million people in China living with atrial fibrillation (AF), this approval marks our commitment […]
Philips picks Ling Liu to lead efforts in China
Philips (NYSE:PHG) announced today that it appointed Ling Liu as chief region leader of Philips Greater China, effective immediately. Liu joined the company’s executive committee as well, reporting to CEO Roy Jakobs. She succeeds Andy Ho, who retired from his post. Ho plans to work with Liu to ensure a smooth transition. “Ling is a […]
Medline plastic syringe recall expands
The FDA says Medline initiated additional recalls as the company grapples with issues surrounding syringes made in China. Medline’s latest recalls aim to stop using affected products that include bulk unauthorized plastic syringes made in China and bulk plastic syringes made in China with performance testing failures. These add to last month’s recalls asking customers […]
Medtronic renal denervation system wins approval in China
Medtronic today announced its Symplicity Spyral renal denervation system won National Medical Products Administration (NMPA) approval in China. Symplicity Spyral is the first high-blood-pressure-treating renal denervation (RDN) system to be approved by China’s NMPA. The company said it intends to go through the provincial registration process and expects sales of the RDN system in China […]
Report: Boston Scientific to open first China factory in Shanghai
According to reports, U.S.-based medtech company Boston Scientific says it intends to open its first factory in China. Reuters reported that Boston Scientific shared the news in a statement on its WeChat social media account. The report said the company shared its interest in expanding regional production in supply chains. Its factory will be in […]
GE HealthCare is expanding its partnership with Sinopharm in China
GE HealthCare (Nasdaq:GEHC) is forming a long-term joint venture with Sinopharm as it seeks to make additional inroads in China’s medical device market. Shanghai-based Sinopharm is one of the largest life science products companies in the world. Its pharmaceutical business alone — with roughly $60 billion in annual revenue — places it at No. 2 […]
